Guidelines : Atopic dermatitis
Detail
Condition :
Atopic dermatitis
Keywords :
JAK, Janus-associated tyrosine kinase , Interleukin, immunomodulator, AD, dermatology, interleukin-4, interleukin-13
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
02 October 2024
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the reviewed and updated Atopic Dermatitis immunomodulator treatment pathway.
N/A
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Atopic dermatitis.
- Abrocitinib Red
- Baricitinib Red
- Dupilumab Red
- Lebrikizumab Red
- Pimecrolimus Blue
- Tacrolimus (topical) Blue
- Tralokinumab Red
- Upadacitinib Red